Insulin-Chitosan Polyelectrolyte anocomplexes: Preparation, Characterization and Stabilization of Insulin

Authors

  • Amani Elsayed Assistant Prof., Faculty of Pharmacy, University of Gezira, Wad Medani, Sudan
  • Mayyas Al-Remawi Assistant Prof., Suwagh for drug delivery systems, subsidiary of the Jordanian Pharmaceutical Manufacturing Co., Plc., Naor, Jordan
  • Asim Farouk Prof., Faculty of Pharmacy, Omdurman Islamic University,Omdurman, Sudan
  • Adnan Badwan Dr.General Manager of the Jordanian Pharmaceutical Manufacturing Company (JPM)

DOI:

https://doi.org/10.52981/sjms.v5i2.996

Keywords:

Insulin, Chitosan, Polyelectrolyte complexes, Nanoparticles

Abstract

Objectives: To formulate chitosan nanoparticles with specific combinations of molecular weight and
degree of deacetylation (DDA) that could be developed into an oral insulin delivery system.
Methods: This study was conducted at Jordanian Pharmaceutical Manufacturing Company (JPM),
Jordan in the period 2006-2009.
Nanoparticles were prepared by polyelectrolyte complexation method (PEC). The physicochemical
characteristics of the nanoparticles were evaluated. The role of nanoparticles in stabilization of insulin
at high temperature and protecting insulin from pancreatic degradation was investigated.
Results: The PEC formation process is influenced by a variety of parameters, including the system
pH, chitosan molecular weight and DDA. The most important factor appears to be the system pH.
All insulin-chitosan complexes displayed positive zeta potential. PECs protect insulin from
pancreatin and the protective ability affected by DDA of chitosan. The results of insulin stability
indicate that insulin-chitosan PEC protects insulin from degradation for at least 24 h.
Conclusions: Molecular parameters of chitosan nanoparticles play an important role in stabilization
of insulin in the GIT. So we can modulate relative parameters to develop an oral insulin delivery
system.

References

Vila A, Sa´ nchez A., Tobh o M. et al. Design of biodegradable particles for protein delivery. J. Control. Release 2002; 78: 15–24.

Nagamoto T., Hattori Y., Takayama, K. et al. Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. Pharm. Res.2004; 21: 671-674.

Lavertu M, Methot S, Tran-Khanh N et al. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials 2006; 27: 4815–4824.

Muzzarelli R, Baldassarre V, Conti F et al. Biological activity of chitosan: ultrastructural study. Biomaterials1988; 9: 247-52.

Illum L., Farraj N.F Davis, S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res.1994; 11: 1186-1189.

Bernkop-Schnurch, A. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int. J. Pharm.2000; 194: 1-13.

Agnihotri S., Mallikarjuna N. Aminabhavi, T. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J. Control. Release 2004; 100: 5-28.

Pan Y., Li Y.J., Zhao H.Y. et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int. J. Pharm.2002; 249: 139-147.

Ma Z., Lim, T.M. Lim, L.Y. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabeticrats. Int. J. Pharm.2005; 293: 271-280.

Mao S., Bakowsky U., Jintapattanakit A. et al. Selfassembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin. J. Pharm. Sci 2006; 95: 1035-1048.

Hejazi R. Amiji, M. Chitosan-based gastrointestinal delivery systems. J. Control. Release 2003; 89: 151- 165.

Sabnis S. Block, L. Chitosan as an enabling excipient for drug delivery systems. 1. Molecular modifications. International journal of Biological Macromolecules 2000; 27: 181-186.

Chae S., Jang M., Nah J. Influence of molecular weight on oral absorption of water soluble chitosans. J. Control. Release 2005; 102: 383-394.

Kasaai M.R. Calculation of Mark-Houwink-Sakurada .MHS; equation viscometric constants for chitosan in any solvent-temperature system using experimental reported viscometric constants data. Carbohydr. Polym.2007; 68: 477-488.

Xu X, Fu Y, Hu H, et al. Quantitative determination of insulin entrapment efficiency in triblock copolymeric nanoparticles by highperformance liquid chromatography. J Pharm Biomed Anal. 2006, 41: 266-273.

Sadeghi A, Dorkoosh F, M. Avadi, M, et al. Preparation, characterization and antibacterial activities of chitosan, Ntrimethyl chitosan .TMC; and N-diethylmethyl chitosan .DEMC;nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods. Int J Pharm. 2008, 355: 299–306.

Lee, M, Var F, Shin-ya Y, Kajiuchi, T, et al. Optimum conditions for the precipitation of chitosan oligomers with DP 5–7 in concentrated hydrochloric acid at low temperature. Process Biochem. 1999, 34: 493–500.

Varum K, Ottoy, M, Smidsrd, O. Acid hydrolysis of chitosans, Carbohydr Polym. 2001, 46: 89–98.

Kumar B. Varadaraj M. Tharanathan, R. Low molecular weight chitosan--preparation with the aid of pepsin, characterization, and its bactericidal activity. Biomacromolecules 2007; 8: 566-572.

Varum K., Attoy M. Smidsrod O. Acid hydrolysis of chitosans. Carbohydr. Polym. 2006; 46: 89-98.

Berger J., Reist M., Mayer, J. et al. Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical application. Eur. J. Pharm. Biopharm.2004; 57: 35-52.

G.A.F. Roberts. Chitin Chemistry, The Mac Millan Press, London, 1992. pp. 1–7.

Kaarsholm N.C., Havelund S., Hougaard P. Ionization behavior of native and mutant insulins: pK perturbation of B13-Glu in aggregated species. Arch Biochem Biophy.1990; 283: 496-502.

Ma Z., Yeoh H.H. Lim, L.Y. Formulation pH modulates the interaction of insulin with chitosan nanoparticles. J. Pharm. Sci.2002; 91: 1396-1404.

Gan, Q. Wang, T. Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release. Colloids Surf. B Biointerfaces 2007; 59: 24-34.

Illum L., Jabbal-Gill I., HinchcliffeM. et al. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev. 2001; 23: 81-96.

Xu Y. Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int. J. Pharm.2003; 250: 215-226.

Zhu S., Qian F., Zhang Y. et al. Synthesis and characterization of PEG modified Ntrimethylaminoethylmethacrylate chitosan nanoparticles, Eur. Polym. J.2007; 43: 2244–2253.

Qun, G. Ajun, W. Effects of molecular weight, degree of acetylation and ionic strength on surface tension of chitosan in dilute solution Carbohydr. Polym.2006: 64: 29-36.

Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals Int. J. Pharm.1999; 185: 129-188.

Chehin R. Thorolfsson M. Knappskog P. Domain structure and stability of human phenylalanine hydroxylase inferred from infrared spectroscopy.FEBS Lett. 422 .1998; 225–230.

McIntosh K., Charman W. Charman S. The application of capillary electrophoresis for monitoring effects of excipients on protein conformation. J. Pharm. Biomed. Anal. 16: .1998; 1097-1105.

Sarmento B., Martins S., Rebeiro A. et al.. Development and comparison of different nanoparticulate polyelectrolyte complexes as insulin carriers. Int. J. Peptide Res.Therap.2006; 12: 131-138.

Oliva A., Farina, J. Llabres, M. Influence of temperature and shaking on stability of insulin preparations: degradation kinetics. Int. J. Pharm .1996; 143: 163-170.

BrangeJ., Langkjaer L, Havelund, S. Hougaard, P. Chemical stability of insulin. 2. Formation of higher molecular weight transformation products during storage of pharmaceutical preparations. Pharm. Res.1992; 9: 727-734.

Brange J., Andersen, L., Laursen, E.D. et al. Toward understanding insulin fibrillation. J. Pharm. Sci.1997; 86: 517-525.

Jintapattanakit A., Junyaprasert V., Mao S. et al. Peroral delivery of insulin using chitosan derivatives: A comparative study of polyelectrolyte nanocomplexes and nanoparticles. Int. J. Pharm.2007; 342: 240-249.

Taluja A. Bae Y. Role of a novel excipient poly .ethylene glycol;-b-poly .L-Histidine; in retention of physical stability of insulin in aqueous solution. Pharm. Res.2007; 24: 1517-1526.

Wu Z., Ping Q., Song, Y. et al. Studies on the insulinliposomes double-coated by chitosan and chitosanEDTA conjugates. Yao Xue Xue Bao. 2004; 39: 933- 938.

Elsayed A, Remawi MA, Qinna N, et al. Formulation and characterization of an oily-based system for oral delivery of insulin. Eur J Pharm Biopharm. 2009; 73: 269-279.

Badwan A, Remawi M, Qinna N, et al. Enhancement of oral bioavailability of insulin in humans Neuroendocrinol Lett 2009; 30: 101-105.

Downloads

Published

2021-08-18

Issue

Section

Original Articles